Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)
Beijing, Beijing Municipality, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm | Recruiting | Phase 2 | 2026-07-15 | NCT07704177 | |
| Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer | Biliary Tract Neoplasms Immunotherapy | Recruiting | Phase 2 | 2025-12-09 | NCT06230471 | |
| Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 1 | 2024-04-12 | NCT06363006 | |
| Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation | Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, adenocarcinoma, carcinoma, connective tissue neoplasm, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, osteosarcoma, sarcoma | Not yet recruiting | Phase 2 | 2023-09-18 | NCT06041490 |